These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2005985)

  • 41. HIV-related risk-taking behaviour, knowledge and serostatus of intravenous drug users in Sydney.
    Wolk J; Wodak A; Morlet A; Guinan JJ; Gold J
    Med J Aust; 1990 May; 152(9):453-8. PubMed ID: 2381335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam.
    Hartgers C; van den Hoek A; Krijnen P; Coutinho RA
    Am J Public Health; 1992 Apr; 82(4):547-51. PubMed ID: 1312311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV seroprevalence in injection drug users.
    Watters JK; Bluthenthal RN; Kral AH
    JAMA; 1995 Apr; 273(15):1178. PubMed ID: 7707623
    [No Abstract]   [Full Text] [Related]  

  • 44. Preventing the spread of HIV among Australian injecting drug users.
    Wodak A
    Forensic Sci Int; 1993 Nov; 62(1-2):83-7. PubMed ID: 8300039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential cofactors in the outcomes of HIV infection in intravenous drug users.
    Des Jarlais DC
    NIDA Res Monogr; 1991; 109():115-23. PubMed ID: 1753988
    [No Abstract]   [Full Text] [Related]  

  • 46. Maximum impact of HIV prevention measures targeted at injecting drug users.
    van Ameijden EJ; Coutinho RA
    AIDS; 1998 Apr; 12(6):625-33. PubMed ID: 9583603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuing injecting risk behaviour: results from the Amsterdam Cohort Study of drug users.
    Van Ameijden EJ; Langendam MW; Notenboom J; Coutinho RA
    Addiction; 1999 Jul; 94(7):1051-61. PubMed ID: 10707443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam.
    van Ameijden EJ; van den Hoek JA; van Haastrecht HJ; Coutinho RA
    Am J Epidemiol; 1992 Jul; 136(2):236-43. PubMed ID: 1415145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands.
    van Haastrecht HJ; van den Hoek JA; Bardoux C; Leentvaar-Kuypers A; Coutinho RA
    Am J Public Health; 1991 Jan; 81(1):59-62. PubMed ID: 1983918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural history of HIV infection in gay men and intravenous drug users.
    Friedland G
    NIDA Res Monogr; 1991; 109():29-50. PubMed ID: 1753990
    [No Abstract]   [Full Text] [Related]  

  • 51. Declining prevalence of HIV infection among injecting drug users entering drug treatment in Italy: 1990-1991.
    Rezza G; De Rose A; Dorrucci M; Arpino C; Serafin I
    Eur J Epidemiol; 1993 Nov; 9(6):663-6. PubMed ID: 8150071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sharing spoons: a risk factor for HIV-1 infection in Vienna.
    Loimer N; Werner E; Presslich O
    Br J Addict; 1991 Jun; 86(6):775-8. PubMed ID: 1878627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring HIV trends in injecting drug users: an Italian experience.
    Zaccarelli M; Rezza G; Girardi E; Puro V; Pezzotti P; Lelli V; Narciso P
    AIDS; 1990 Oct; 4(10):1007-10. PubMed ID: 2261114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychopathology, stress and HIV-risk injecting behaviour among drug users.
    Hartgers C; Van den Hoek JA; Coutinho RA; Van der Pligt J
    Br J Addict; 1992 Jun; 87(6):857-65. PubMed ID: 1525529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of four survey methods designed to estimate the prevalence of HIV among female prostitutes who inject drugs.
    Goldberg D; Green ST; Taylor A; Frischer M; McKeganey N
    Int J STD AIDS; 1994; 5(3):186-8. PubMed ID: 8061089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Constant information is needed to prevent the spread of HIV-1 in Italy.
    Luzi G; Mezzaroma I; d'Offizi G; Valdarchi C; Aiuti F
    Allergol Immunopathol (Madr); 1991; 19(4):174-5. PubMed ID: 1818518
    [No Abstract]   [Full Text] [Related]  

  • 57. HIV infection and risk behaviors among intravenous drug users in low seroprevalence areas in the Midwest.
    Siegal HA; Carlson RG; Falck R; Li L; Forney MA; Rapp RC; Baumgartner K; Myers W; Nelson M
    Am J Public Health; 1991 Dec; 81(12):1642-4. PubMed ID: 1746663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protease inhibitors in HIV-infected injecting drug users in Amsterdam: cumulative incidence, determinants and impact.
    Schinkel J; Coutinho RA; van Ameijden EJ
    AIDS; 1998 Jul; 12(10):1247-9. PubMed ID: 9677178
    [No Abstract]   [Full Text] [Related]  

  • 59. Political and systemic barriers increasing risk of HIV for injecting drug users in East Africa.
    Wolfe D; Csete J
    Addiction; 2010 Oct; 105(10):1859. PubMed ID: 20712813
    [No Abstract]   [Full Text] [Related]  

  • 60. Did the Taliban's opium eradication campaign cause a decline in HIV infections in Russia?
    Rosenblum D; Jones M
    Subst Use Misuse; 2013 Apr; 48(6):470-6. PubMed ID: 23528145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.